作者
Thomas Danne, T Battelino, P Jarosz-Chobot, O Kordonouri, E Pánkowska, Johnny Ludvigsson, E Schober, Eero Kaprio, Tero Saukkonen, M Nicolino, N Tubiana-Rufi, C Klinkert, H Haberland, A Vazeou, L Madacsy, D Zangen, V Cherubini, I Rabbone, S Toni, C De Beaufort, W Bakker-van Waarde, N Van Den Berg, I Volkov, R Barrio, R Hanas, U Zumsteg, B Kuhlmann, Christoph Aebi, U Schumacher, S Gschwend, P Hindmarsh, M Torres, N Shehadeh, M Phillip, PedPump Study Group
发表日期
2008/9
期刊
Diabetologia
卷号
51
页码范围
1594-1601
出版商
Springer-Verlag
简介
Aims/hypothesis
To assess the use of paediatric continuous subcutaneous infusion (CSII) under real-life conditions by analysing data recorded for up to 90 days and relating them to outcome.
Methods
Pump programming data from patients aged 0–18 years treated with CSII in 30 centres from 16 European countries and Israel were recorded during routine clinical visits. HbA1c was measured centrally.
Results
A total of 1,041 patients (age: 11.8 ± 4.2 years; diabetes duration: 6.0 ± 3.6 years; average CSII duration: 2.0 ± 1.3 years; HbA1c: 8.0 ± 1.3% [means ± SD]) participated. Glycaemic control was better in preschool (n = 142; 7.5 ± 0.9%) and pre-adolescent (6–11 years, n = 321; 7.7 ± 1.0%) children than in adolescent patients (12–18 years, n = 578; 8.3 ± 1.4%). There was a significant negative …
引用总数
学术搜索中的文章
T Danne, T Battelino, P Jarosz-Chobot, O Kordonouri… - Diabetologia, 2008